Coherus Oncology, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Coherus Oncology, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $40.90M.
- Coherus Oncology, Inc. stock issued during period, value, new issues for fiscal 2025 was $7.89M.
- Coherus Oncology, Inc. stock issued during period, value, new issues for fiscal 2022 was $6.13M, a 85.00% decline from fiscal 2021.
- Coherus Oncology, Inc. stock issued during period, value, new issues for fiscal 2021 was $40.90M.
- Coherus Oncology, Inc. stock issued during period, value, new issues for fiscal 2019 was $8.23M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $7.89M 10-K · filed 2026-03-09 | |
| 2022-12-31 | $6.13M 10-K · filed 2025-03-17 | |
| 2021-12-31 | $40.90M 10-K · filed 2024-03-15 | |
| 2021-06-30 | $40.90M 10-Q · filed 2022-11-08 | |
| 2019-12-31 | $8.23M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |